The role of calcitonin gene–related peptide in peripheral and central pain mechanisms including migraine

von Iyengar, Smriti, Ossipov, Michael H., Johnson, Kirk W.
Veröffentlicht in Pain (2017)

The glial cell modulator and phosphodiesterase inhibitor, AV411 (ibudilast), attenuates prime- and stress-induced methamphetamine relapse

von Beardsley, Patrick M., Shelton, Keith L., Hendrick, Elizabeth, Johnson, Kirk W.
Veröffentlicht 2010

CGRP and the Trigeminal System in Migraine

von Iyengar, Smriti, Johnson, Kirk W., Ossipov, Michael H., Aurora, Sheena K.
Veröffentlicht in Headache (2019)

The Glial Activation Inhibitor AV411 Reduces Morphine-Induced Nucleus Accumbens Dopamine Release

von Bland, Sondra T., Hutchinson, Mark R., Maier, Steven F., Watkins, Linda R., Johnson, Kirk W.
Veröffentlicht 2009

Methodology for Rapid Measures of Glutamate Release in Rat Brain Slices Using Ceramic-Based Microelectrode Arrays: Basic Characterization and Drug Pharmacology

von Quintero, Jorge E., Pomerleau, François, Huettl, Peter, Johnson, Kirk W., Offord, James, Gerhardt, Greg A.
Veröffentlicht 2011

Opioid-Induced Glial Activation: Mechanisms of Activation and Implications for Opioid Analgesia, Dependence, and Reward

von Hutchinson, Mark R., Bland, Sondra T., Johnson, Kirk W., Rice, Kenner C., Maier, Steven F., Watkins, Linda R.
Veröffentlicht in ScientificWorldJournal (2007)

Lasmiditan mechanism of action – review of a selective 5-HT(1F) agonist

von Clemow, David B., Johnson, Kirk W., Hochstetler, Helen M., Ossipov, Michael H., Hake, Ann M., Blumenfeld, Andrew M.
Veröffentlicht in J Headache Pain (2020)

Ibudilast reduces alcohol drinking in multiple animal models of alcohol-dependence

von Bell, Richard L., Lopez, Marcelo F., Cui, Changhai, Egli, Mark, Johnson, Kirk W., Franklin, Kelle M., Becker, Howard C.
Veröffentlicht 2013

Intrathecal Injection of Naked Plasmid DNA Provides Long-term Expression of Secreted Proteins

von Hughes, Travis S, Langer, Stephen J, Johnson, Kirk W, Chavez, Raymond A, Watkins, Linda R, Milligan, Erin D, Leinwand, Leslie A
Veröffentlicht 2008

Systemic Administration of Propentofylline, Ibudilast, and (+)-Naltrexone Each Reverses Mechanical Allodynia in a Novel Rat Model of Central Neuropathic Pain

von Ellis, Amanda, Wieseler, Julie, Favret, Jacob, Johnson, Kirk W., Rice, Kenner C., Maier, Steven F., Falci, Scott, Watkins, Linda R.
Veröffentlicht 2014

PEGylation of interleukin-10 for the mitigation of enhanced pain states

von Soderquist, Ryan G., Milligan, Erin D., Harrison, Jacqueline A., Chavez, Raymond A., Johnson, Kirk W., Watkins, Linda R., Mahoney, Melissa J.
Veröffentlicht 2010

Evaluation of LY573144 (lasmiditan) in a preclinical model of medication overuse headache

von Rau, Jill C, Navratilova, Edita, Oyarzo, Janice, Johnson, Kirk W, Aurora, Sheena K, Schwedt, Todd J, Dodick, David W, Porreca, Frank
Veröffentlicht in Cephalalgia (2020)

Ibudilast in healthy volunteers: safety, tolerability and pharmacokinetics with single and multiple doses

von Rolan, Paul, Gibbons, Jacqueline A, He, Lin, Chang, Eppie, Jones, Drew, Gross, Matthew I, Davidson, Jennifer Bahr, Sanftner, Laura M, Johnson, Kirk W
Veröffentlicht 2008

Reversal of Established Traumatic Brain Injury-Induced, Anxiety-Like Behavior in Rats after Delayed, Post-Injury Neuroimmune Suppression

von Rodgers, Krista M., Deming, Yuetiva K., Bercum, Florencia M., Chumachenko, Serhiy Y., Wieseler, Julie L., Johnson, Kirk W., Watkins, Linda R., Barth, Daniel S.
Veröffentlicht 2014

Effects of Ibudilast on the Subjective, Reinforcing, and Analgesic Effects of Oxycodone in Recently Detoxified Adults with Opioid Dependence

von Metz, Verena E, Jones, Jermaine D, Manubay, Jeanne, Sullivan, Maria A, Mogali, Shanthi, Segoshi, Andrew, Madera, Gabriela, Johnson, Kirk W, Comer, Sandra D
Veröffentlicht in Neuropsychopharmacology (2017)

Acute Neuroimmune Modulation Attenuates the Development of Anxiety-Like Freezing Behavior in an Animal Model of Traumatic Brain Injury

von Rodgers, Krista M., Bercum, Florencia M., McCallum, Danielle L., Rudy, Jerry W., Frey, Lauren C., Johnson, Kirk W., Watkins, Linda R., Barth, Daniel S.
Veröffentlicht 2012

Effect of Different Doses of Galcanezumab vs Placebo for Episodic Migraine Prevention: A Randomized Clinical Trial

von Skljarevski, Vladimir, Oakes, Tina M., Zhang, Qi, Ferguson, Margaret B., Martinez, James, Camporeale, Angelo, Johnson, Kirk W., Shan, Qiuling, Carter, Jeffrey, Schacht, Aaron, Goadsby, Peter J., Dodick, David W.
Veröffentlicht in JAMA Neurol (2017)

CGRP receptor activity in mice with global expression of human receptor activity modifying protein 1

von Bohn, Keegan J, Li, Baolin, Huang, Xiaofang, Mason, Bianca N, Wattiez, Anne‐Sophie, Kuburas, Adisa, Walker, Christopher S, Yang, Peiyi, Yu, Jianliang, Heinz, Beverly A, Johnson, Kirk W, Russo, Andrew F
Veröffentlicht in Br J Pharmacol (2017)

Lasmiditan inhibits calcitonin gene-related peptide release in the rodent trigeminovascular system

von Labastida-Ramírez, Alejandro, Rubio-Beltrán, Eloísa, Haanes, Kristian A., Chan, Kayi Y., Garrelds, Ingrid M., Johnson, Kirk W., Danser, Alexander H.J., Villalón, Carlos M., MaassenVanDenBrink, Antoinette
Veröffentlicht in Pain (2020)

The glial modulatory drug AV411 attenuates mechanical allodynia in rat models of neuropathic pain

von LEDEBOER, ANNEMARIE, LIU, TONGYAO, SHUMILLA, JENNIFER A., MAHONEY, JOHN H., VIJAY, SHARMILA, GROSS, MATTHEW I., VARGAS, JOSEPH A., SULTZBAUGH, LANCE, CLAYPOOL, MARK D., SANFTNER, LAURA M., WATKINS, LINDA R., JOHNSON, KIRK W.
Veröffentlicht 2007